Justin Thacker, Vice President, Finance at Design Therapeutics, Inc. (DSGN), bought 17,500 shares at $20.00 ($350K) on 2021-03-30, disclosed to the SEC on 2021-04-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.